BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37967237)

  • 21. Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.
    Dietz S; Christopoulos P; Yuan Z; Angeles AK; Gu L; Volckmar AL; Ogrodnik SJ; Janke F; Fratte CD; Zemojtel T; Schneider MA; Kazdal D; Endris V; Meister M; Muley T; Cecchin E; Reck M; Schlesner M; Thomas M; Stenzinger A; Sültmann H
    EBioMedicine; 2020 Dec; 62():103103. PubMed ID: 33161228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA.
    Xi W; Zhou C; Xu F; Sun D; Wang S; Chen Y; Ji J; Ma T; Wu J; Shangguan C; Zhu Z; Zhang J
    J Transl Med; 2022 Aug; 20(1):365. PubMed ID: 35962408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of next-generation sequencing to detect
    Iacocca MA; Wang J; Dron JS; Robinson JF; McIntyre AD; Cao H; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2202-2209. PubMed ID: 28874442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SILO: A Computational Method for Detecting Copy Number Gain in Clinical Specimens Analyzed on a Next-Generation Sequencing Platform.
    Miller N; Bouma M; Sabatini L; Gulukota K
    J Mol Diagn; 2021 Oct; 23(10):1241-1248. PubMed ID: 34365010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification.
    Cao Y; Jin Y; Yu J; Wang J; Qiu Y; Duan X; Ye Y; Cheng Y; Dong L; Feng X; Wang D; Li Z; Tian X; Wang H; Yan J; Zhao Q
    Oncotarget; 2017 Jul; 8(30):49689-49701. PubMed ID: 28591696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CNV Detection from Exome Sequencing Data in Routine Diagnostics of Rare Genetic Disorders: Opportunities and Limitations.
    Royer-Bertrand B; Cisarova K; Niel-Butschi F; Mittaz-Crettol L; Fodstad H; Superti-Furga A
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
    Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
    Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
    [No Abstract]   [Full Text] [Related]  

  • 28. Concordance rate between copy number variants detected using either high- or medium-density single nucleotide polymorphism genotype panels and the potential of imputing copy number variants from flanking high density single nucleotide polymorphism haplotypes in cattle.
    Rafter P; Gormley IC; Parnell AC; Kearney JF; Berry DP
    BMC Genomics; 2020 Mar; 21(1):205. PubMed ID: 32131735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noise cancellation using total variation for copy number variation detection.
    Zare F; Hosny A; Nabavi S
    BMC Bioinformatics; 2018 Oct; 19(Suppl 11):361. PubMed ID: 30343665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copy number variation is highly correlated with differential gene expression: a pan-cancer study.
    Shao X; Lv N; Liao J; Long J; Xue R; Ai N; Xu D; Fan X
    BMC Med Genet; 2019 Nov; 20(1):175. PubMed ID: 31706287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population clustering based on copy number variations detected from next generation sequencing data.
    Duan J; Zhang JG; Wan M; Deng HW; Wang YP
    J Bioinform Comput Biol; 2014 Aug; 12(4):1450021. PubMed ID: 25152046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Copy Number Alterations from Next-Generation Sequencing Data.
    Nabavi S; Zare F
    Adv Exp Med Biol; 2022; 1361():55-74. PubMed ID: 35230683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
    Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
    J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach.
    Bhai P; Levy MA; Rooney K; Carere DA; Reilly J; Kerkhof J; Volodarsky M; Stuart A; Kadour M; Panabaker K; Schenkel LC; Lin H; Ainsworth P; Sadikovic B
    Front Genet; 2021; 12():698595. PubMed ID: 34326862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Pathological Characteristics of
    Frank R; Scheffler M; Merkelbach-Bruse S; Ihle MA; Kron A; Rauer M; Ueckeroth F; König K; Michels S; Fischer R; Eisert A; Fassunke J; Heydt C; Serke M; Ko YD; Gerigk U; Geist T; Kaminsky B; Heukamp LC; Clement-Ziza M; Büttner R; Wolf J
    Clin Cancer Res; 2018 Jul; 24(13):3087-3096. PubMed ID: 29615460
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.
    Nagano C; Nozu K; Morisada N; Yazawa M; Ichikawa D; Numasawa K; Kourakata H; Matsumura C; Tazoe S; Tanaka R; Yamamura T; Minamikawa S; Horinouchi T; Nakanishi K; Fujimura J; Sakakibara N; Nozu Y; Ye MJ; Kaito H; Iijima K
    Clin Exp Nephrol; 2018 Aug; 22(4):881-888. PubMed ID: 29372472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-Specific eQTL in Zebrafish.
    Dobrinski KP
    Methods Mol Biol; 2020; 2082():239-249. PubMed ID: 31849020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of cancers based on copy number variation landscapes.
    Zhang N; Wang M; Zhang P; Huang T
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2750-5. PubMed ID: 27266344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pan-cancer landscape of pathogenic somatic copy number variations.
    Becchi T; Beltrame L; Mannarino L; Calura E; Marchini S; Romualdi C
    J Biomed Inform; 2023 Nov; 147():104529. PubMed ID: 37858853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.